IS6021A - Pharmaceutical formulations containing citalopram - Google Patents

Pharmaceutical formulations containing citalopram

Info

Publication number: IS6021A
Authority: IS; Iceland
Prior art keywords: pharmaceutical formulations; formulations containing; containing citalopram; citalopram; pharmaceutical
Prior art date: 2000-08-10

Application number

IS6021A

Other languages

Icelandic (is)

Inventor

Liljegren Ken

Holm Per

Nielsen Ole

Wagner Swen

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-24

Publication date

2001-10-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-07-24 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2001-10-20 Publication of IS6021A publication Critical patent/IS6021A/en

Links

WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 title 1
229960001653 citalopram Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS6021A 2000-08-10 2001-07-24 Pharmaceutical formulations containing citalopram IS6021A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200001202		2000-08-10
DKPA200001614		2000-10-27

Publications (1)

Publication Number	Publication Date
IS6021A true IS6021A (en)	2001-10-20

Family

ID=26068858

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6021A IS6021A (en)	2000-08-10	2001-07-24	Pharmaceutical formulations containing citalopram

Country Status (34)

Country	Link
EP (1)	EP1318805A2 (en)
JP (1)	JP2003531153A (en)
KR (1)	KR20030024833A (en)
CN (1)	CN1446089A (en)
AR (1)	AR030095A1 (en)
AT (1)	AT5744U1 (en)
AU (2)	AU2001100198B4 (en)
BE (1)	BE1013559A6 (en)
BG (1)	BG107578A (en)
BR (1)	BR0113250A (en)
CA (1)	CA2353693C (en)
CH (2)	CH694241A5 (en)
CZ (1)	CZ2003397A3 (en)
DE (2)	DE20113195U1 (en)
EA (1)	EA200300247A1 (en)
ES (1)	ES2172481B2 (en)
FI (1)	FI5176U1 (en)
FR (1)	FR2812811B1 (en)
GB (1)	GB2368014B (en)
GR (1)	GR1004193B (en)
HR (1)	HRP20030054A2 (en)
HU (1)	HUP0103071A3 (en)
IE (1)	IES20010693A2 (en)
IL (1)	IL154050A0 (en)
IS (1)	IS6021A (en)
IT (1)	ITMI20011637A1 (en)
MX (1)	MXPA03000837A (en)
NL (1)	NL1018741C1 (en)
NO (1)	NO20013891L (en)
NZ (1)	NZ523785A (en)
PL (1)	PL359824A1 (en)
SK (1)	SK2842003A3 (en)
WO (1)	WO2001080619A2 (en)
YU (1)	YU9003A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2353693C (en) *	2000-08-10	2003-07-22	H. Lundbeck A/S	Pharmaceutical composition containing citalopram
AU2001100195B4 (en) *	2001-01-05	2001-12-20	H Lundbeck As	Pharmaceutical composition containing citalopram.
GB0206708D0 (en) *	2002-03-21	2002-05-01	Cipla Ltd	Pharmaceutical salts
US6812355B2 (en)	2002-10-22	2004-11-02	Sekhsaria Chemicals Limited	Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
CN100349885C (en) *	2002-12-23	2007-11-21	H·隆德贝克有限公司	Crystalline escitalopram hydrobromide and methods for preparing the same
WO2004103361A2 (en) *	2003-05-20	2004-12-02	Ranbaxy Laboratories Limited	A pharmaceutical dosage form of citalopram
HU227491B1 (en) *	2003-11-25	2011-07-28	Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag	Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) *	2004-10-05	2006-04-13	Strides Acrolab Limited	An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) *	2006-01-05	2007-12-12	昆明积大制药有限公司	Antidepressant composition containing citalopram and cyclodextrin
GB2480191A (en) *	2007-02-02	2011-11-09	Ubiquisys Ltd	Determining the location of a base station
CN106397249A (en) *	2015-08-03	2017-02-15	深圳信立泰药业股份有限公司	High-stability LCZ696 crystallized powder and a preparing method thereof
WO2022153262A1 (en) *	2021-01-18	2022-07-21	Anton Frenkel	Pharmaceutical dosage form
WO2024165628A1 (en)	2023-02-07	2024-08-15	Kinast Lasse	An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content
CN116656399B (en) *	2023-04-23	2026-03-03	攀钢集团西昌钢钒有限公司	Parallel desulfurizing tower group
CN117771201A (en) *	2023-09-28	2024-03-29	浙江普洛康裕制药有限公司	A kind of nitrofurantoin large crystal capsule and its preparation process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1358915A (en) *	1919-04-14	1920-11-16	Amici Domenico	Aeroplane
GB1358915A (en) *	1971-09-13	1974-07-03	Merck & Co Inc	Directly compressed tablet and composition therefor
GB1526331A (en)	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en)	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of a drug by a serotonin 1A receptor antagonist
GB9714841D0 (en) *	1997-07-14	1997-09-17	Smithkline Beecham Plc	Treatment method
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en)	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) *	2000-08-10	2003-07-22	H. Lundbeck A/S	Pharmaceutical composition containing citalopram

2001
- 2001-07-24 CA CA002353693A patent/CA2353693C/en not_active Expired - Lifetime
- 2001-07-24 IS IS6021A patent/IS6021A/en unknown
- 2001-07-24 IE IE20010693A patent/IES20010693A2/en not_active IP Right Cessation
- 2001-07-26 AU AU2001100198A patent/AU2001100198B4/en not_active Expired
- 2001-07-26 HU HU0103071A patent/HUP0103071A3/en unknown
- 2001-07-27 IT IT2001MI001637A patent/ITMI20011637A1/en unknown
- 2001-07-30 KR KR10-2003-7001683A patent/KR20030024833A/en not_active Ceased
- 2001-07-30 YU YU9003A patent/YU9003A/en unknown
- 2001-07-30 PL PL01359824A patent/PL359824A1/en not_active Application Discontinuation
- 2001-07-30 NZ NZ523785A patent/NZ523785A/en unknown
- 2001-07-30 CN CN01813752A patent/CN1446089A/en active Pending
- 2001-07-30 HR HR20030054A patent/HRP20030054A2/en not_active Application Discontinuation
- 2001-07-30 AU AU2001279591A patent/AU2001279591A1/en not_active Abandoned
- 2001-07-30 MX MXPA03000837A patent/MXPA03000837A/en unknown
- 2001-07-30 JP JP2001577732A patent/JP2003531153A/en not_active Withdrawn
- 2001-07-30 EA EA200300247A patent/EA200300247A1/en unknown
- 2001-07-30 WO PCT/DK2001/000520 patent/WO2001080619A2/en not_active Ceased
- 2001-07-30 BR BR0113250-4A patent/BR0113250A/en not_active IP Right Cessation
- 2001-07-30 IL IL15405001A patent/IL154050A0/en unknown
- 2001-07-30 SK SK284-2003A patent/SK2842003A3/en not_active Application Discontinuation
- 2001-07-30 CZ CZ2003397A patent/CZ2003397A3/en unknown
- 2001-07-30 EP EP01957768A patent/EP1318805A2/en not_active Withdrawn
- 2001-07-31 GB GB0118579A patent/GB2368014B/en not_active Expired - Fee Related
- 2001-07-31 GR GR20010100377A patent/GR1004193B/en unknown
- 2001-07-31 AR ARP010103662A patent/AR030095A1/en not_active Application Discontinuation
- 2001-08-07 AT AT0062401U patent/AT5744U1/en not_active IP Right Cessation
- 2001-08-08 FR FR0110586A patent/FR2812811B1/en not_active Expired - Fee Related
- 2001-08-08 CH CH01422/03A patent/CH694241A5/en not_active IP Right Cessation
- 2001-08-08 CH CH01469/01A patent/CH694242A5/en not_active IP Right Cessation
- 2001-08-09 FI FI20010303U patent/FI5176U1/en active
- 2001-08-09 ES ES200101877A patent/ES2172481B2/en not_active Expired - Fee Related
- 2001-08-09 NO NO20013891A patent/NO20013891L/en not_active Application Discontinuation
- 2001-08-09 DE DE20113195U patent/DE20113195U1/en not_active Ceased
- 2001-08-09 DE DE10139115A patent/DE10139115A1/en not_active Ceased
- 2001-08-10 NL NL1018741A patent/NL1018741C1/en not_active IP Right Cessation
- 2001-08-10 BE BE2001/0537A patent/BE1013559A6/en not_active IP Right Cessation
2003
- 2003-02-21 BG BG107578A patent/BG107578A/en unknown

Also Published As

Publication number	Publication date
WO2001080619A2 (en)	2001-11-01
KR20030024833A (en)	2003-03-26
GB2368014B (en)	2004-06-23
ES2172481B2 (en)	2004-08-01
AR030095A1 (en)	2003-08-13
GB2368014A (en)	2002-04-24
YU9003A (en)	2006-05-25
PL359824A1 (en)	2004-09-06
ITMI20011637A1 (en)	2003-01-27
IES20010693A2 (en)	2002-07-10
NZ523785A (en)	2004-09-24
MXPA03000837A (en)	2003-06-06
FI5176U1 (en)	2001-12-27
GR20010100377A (en)	2002-09-06
CA2353693A1 (en)	2002-01-22
FR2812811A1 (en)	2002-02-15
BR0113250A (en)	2003-06-24
WO2001080619A3 (en)	2002-02-21
ES2172481A1 (en)	2002-09-16
HU0103071D0 (en)	2001-10-28
IL154050A0 (en)	2003-07-31
AU2001100198A4 (en)	2001-08-16
BE1013559A6 (en)	2002-03-05
BG107578A (en)	2003-09-30
NO20013891D0 (en)	2001-08-09
AU2001279591A1 (en)	2001-11-07
GB0118579D0 (en)	2001-09-19
AU2001100198B4 (en)	2002-06-13
FR2812811B1 (en)	2006-08-18
ITMI20011637A0 (en)	2001-07-27
AT5744U1 (en)	2002-11-25
DE20113195U1 (en)	2001-11-15
SK2842003A3 (en)	2003-09-11
CZ2003397A3 (en)	2003-06-18
CH694242A5 (en)	2004-10-15
HUP0103071A3 (en)	2002-12-28
HUP0103071A2 (en)	2002-05-29
CA2353693C (en)	2003-07-22
HRP20030054A2 (en)	2005-02-28
EP1318805A2 (en)	2003-06-18
GR1004193B (en)	2003-03-24
DE10139115A1 (en)	2002-03-28
CN1446089A (en)	2003-10-01
NO20013891L (en)	2002-02-11
NL1018741C1 (en)	2002-02-12
EA200300247A1 (en)	2003-06-26
JP2003531153A (en)	2003-10-21
CH694241A5 (en)	2004-10-15

Publication	Publication Date	Title
AR028204A1 (en)	2003-04-30	ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS
FI20105657L (en)	2010-06-10	Pharmaceutical compositions
ITMI20010748A0 (en)	2001-04-06	PHARMACEUTICAL COMPOSITIONS
NO20025450L (en)	2002-11-14	New pharmaceutical composition
DK1524266T3 (en)	2007-06-25	Pharmaceutical composition
IS6263A (en)	2002-02-08	Pharmaceutical formulations containing tripeptide
ITTO20010008A0 (en)	2001-01-10	PHARMACEUTICAL FORMULATION
DK1317177T3 (en)	2004-12-20	Disinfectant formulations
ID23299A (en)	2000-04-05	PHARMACEUTICAL FORMULATIONS
AT7729U3 (en)	2006-01-15	PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINMALEAT
EE05020B1 (en)	2008-06-16	The pharmaceutical composition of G1buride
NO20031597D0 (en)	2003-04-08	Medical aerosol formulations
NO20015670D0 (en)	2001-11-20	Improved pharmaceutical formulations
NO20026123L (en)	2003-02-18	Pharmaceutical compositions
ITMI20011637A0 (en)	2001-07-27	PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM
NO20031095L (en)	2003-03-10	Pharmaceutical compositions
ATE268116T1 (en)	2004-06-15	MESOTRION FORMULATIONS
IS6857A (en)	2003-06-23	Pharmaceutical composition containing citalopram
MXPA03001857A (en)	2003-06-04	MEDICINAL COMPOSITIONS.
EE200200689A (en)	2004-06-15	Pharmaceutical compositions
DK200100203U4 (en)	2003-03-28	Pharmaceutical composition containing citalopram
GB0219820D0 (en)	2002-10-02	Pharmaceutical compostion containing citalopram